FDA Drug Safety: New Warning for Blood Pressure Medicines
The United States Food and Drug Administration released a safety announcement stating possible risks associated with using blood pressure medicines containing aliskiren with other drugs called angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor
FDA Consumer Update: Limit Use of 80 mg Simvastatin
The United States Food and Drug Administration recommends that users of drugs containing 80 mg of simvastatin watch their intake of the drug, due to a risk of muscle injury.  80 mg is the